Position in ICLR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,124,032
+$6,121,074 QoQ
Shares Held
104,335
-3.8% QoQ
Ownership
0.135%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#76
of 422 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 77%
Shared 0%
None 23%
Common Shares in ICLR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026FRONTIER CAPITAL MANAGEMENT CO LLC holds $144,413,741 across 8 Diagnostics & Research names. ICLR ranks #3 (12.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
173,547 | $47,109,333 | |
| 2 | RVTY |
Revvity, Inc.
|
180,771 | $20,112,581 | |
| 3 | ICLR |
Icon PLC
This page
|
104,335 | $18,124,032 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
33,592 | $17,684,172 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
12,655 | $16,166,889 | |
| 6 | A |
Agilent Technologies, Inc.
|
100,214 | $13,311,425 | |
| 7 | CRL |
Charles River Laboratories International, Inc.
|
50,938 | $11,552,229 | |
| 8 | LH |
Labcorp Holdings Inc.
|
1,261 | $353,080 |
All Filings in ICLR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,124,032 | 104,335 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,002,958 | 108,467 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $13,255,411 | 72,744 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $12,125,575 | 69,289 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,379,312 | 71,360 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,318,363 | 36,107 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,021,608 | 19,177 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||